AANS Online Scientific Sessions: Spine and Peripheral Nerve-Predicting Tumor Specific Survival In Patients With Metastatic Renal Cell Carcinoma: Which Scoring System Is Most Accurate?

Predicting Tumor Specific Survival In Patients With Metastatic Renal Cell Carcinoma: Which Scoring System Is Most Accurate?

Video Transcription

Video Summary

In this video presentation, the speaker discusses their research on predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma (RCC). They compare various scoring systems and prediction models to determine overall survivor and tumor-specific survival for RCC patients undergoing surgical treatment for spinal metastatic disease. The study aims to assist spine surgeons in determining the risk-benefit ratio of invasive surgery by estimating prognosis and survival. The speaker presents results from a retrospective review of 86 patients who underwent spine surgery for metastatic RCC, showing that certain prognostic factors have limited value in predicting survival. The New England Spinal Metastatic score performed the best in predicting one-year survival after surgery. The study concludes that standard prediction models for spine metastatic disease have poor to fair performance, and future models should incorporate genetic factors and treatment responses for improved accuracy. The speaker expresses gratitude to Dr. John Chin and Dr. Ganesh Shankar for their support and mentorship.

Asset Subtitle

Elie Massaad

Keywords

tumor-specific survival

spinal metastatic renal cell carcinoma

scoring systems

prediction models

survival prognosis